RECRUITING

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

Description

The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice. This is a two-year prospective data collection study with additional data collection at baseline evaluating medical practice over a period of at least one year before the introduction of the MS care management platform.

Conditions

Relapsing Remitting Multiple Sclerosis
Talk to us

Related Conditions:

Relapsing Remitting Multiple Sclerosis

Study Overview

On this page

Study Details

Study overview

The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice. This is a two-year prospective data collection study with additional data collection at baseline evaluating medical practice over a period of at least one year before the introduction of the MS care management platform.

Study to Evaluate the Usability of Introducing Integrated Digital Solutions Into Clinical Practice and the Value of Their Use in the Medical Care of Patients With Multiple Sclerosis (MS)

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

Condition
Relapsing Remitting Multiple Sclerosis
Intervention / Treatment

-

Contacts and Locations

Golden Valley

Minneapolis Clinic of Neurology, Golden Valley, Minnesota, United States, 55422

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Able to comply with the study protocol, including having a smartphone and being able and willing to access the icompanion ms patient app on a regular basis. To use all functionalities of the icompanion ms patient app, the user's smartphone must comply with the minimum system requirements (Android version 5.0 or above, iOS version 11 or above)
  • * Have a valid email address (for registration of icompanion ms)
  • * Have a definite diagnosis of RRMS
  • * Time since MS diagnosis ≥1 year
  • * Medical history recorded for at least 1 year before enrollment
  • * Expanded Disability Status Scale (EDSS) \<5.5
  • * Any contra-indications to using icompanion ms patient app or website, as per the investigator's discretion
  • * Inability to complete an MRI
  • * Currently involved in an interventional trial
  • * Diagnosis of progressive MS (primary progressive multiple sclerosis \[PPMS\] or secondary progressive multiple sclerosis \[SPMS\])

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Hoffmann-La Roche,

Clinical Trials, STUDY_DIRECTOR, icometrix

Study Record Dates

2026-04-30